T

Tolerx, Inc.

100 employees

Tolerx develops novel therapies that modulate T-cell activities to treat patients with autoimmune diseases, diabetes and cancer.

Basic info

Industry

biotechnology research

Sectors

cancer treatment
Biotechnology
biotechnology
Health Care
immunotherapy
Medical
antibody treatment
autoimmune disease
diabetes treatment

Date founded

2000

Funding rounds raised

Total raised

$61M

from 13 investors over 13 rounds

T

Tolerx, Inc. raised $61M on October 21, 2006

Investors: Duke University, Tenaya Capital, Sky Ventures, HealthCare Ventures LLC and Yasuda Enteprise Development Co. Ltd

T

Tolerx, Inc. raised $31M on March 29, 2005

Investors: Duke University, HealthCare Ventures LLC, Sky Ventures and Yasuda Enteprise Development Co. Ltd

T

Tolerx, Inc. raised $35M on January 10, 2003

Investors: HealthCare Ventures LLC and Yasuda Enteprise Development Co. Ltd

T

Tolerx, Inc. raised $17M on October 24, 2001

Investors: Sky Ventures and HealthCare Ventures LLC

FAQ